Daisuke Sugiyama

8.1k total citations · 1 hit paper
102 papers, 3.7k citations indexed

About

Daisuke Sugiyama is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Daisuke Sugiyama has authored 102 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 33 papers in Cell Biology and 22 papers in Physiology. Recurrent topics in Daisuke Sugiyama's work include Zebrafish Biomedical Research Applications (31 papers), Erythrocyte Function and Pathophysiology (13 papers) and Pluripotent Stem Cells Research (13 papers). Daisuke Sugiyama is often cited by papers focused on Zebrafish Biomedical Research Applications (31 papers), Erythrocyte Function and Pathophysiology (13 papers) and Pluripotent Stem Cells Research (13 papers). Daisuke Sugiyama collaborates with scholars based in Japan, United States and France. Daisuke Sugiyama's co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Kohichiro Tsuji, Kasem Kulkeaw, Toshio Kitamura, Hideaki Nakajima, Yumi Fukuchi, Nancy A. Speck, Shumpei Ishikawa and Hirokazu Taniguchi and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Daisuke Sugiyama

100 papers receiving 3.6k citations

Hit Papers

Human Placenta‐Derived Cells Have Mesenchymal Stem/Progen... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers

Daisuke Sugiyama
Jin Hyen Baek United States
Jeffrey I. Kreisberg United States
Ilsa I. Rovira United States
Saghi Ghaffari United States
Reid Huber United States
Guy Eelen Belgium
Ergün Sahin United States
Linda M. Boxer United States
Jin Hyen Baek United States
Daisuke Sugiyama
Citations per year, relative to Daisuke Sugiyama Daisuke Sugiyama (= 1×) peers Jin Hyen Baek

Countries citing papers authored by Daisuke Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Daisuke Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Sugiyama more than expected).

Fields of papers citing papers by Daisuke Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Sugiyama. The network helps show where Daisuke Sugiyama may publish in the future.

Co-authorship network of co-authors of Daisuke Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Sugiyama. A scholar is included among the top collaborators of Daisuke Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Sugiyama. Daisuke Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogino, Hitoshi, Daisuke Sugiyama, & Ken‐ichi Ueda. (2023). Anaesthetic Management of a Patient With Immune-Mediated Necrotizing Muscle Disease With the Use of a Novel Ultrashort-Acting Benzodiazepine, Remimazolam: A Case Report. Cureus. 15(4). e37326–e37326. 2 indexed citations
2.
Niwa, Yasuharu, et al.. (2022). Research and Development of Oligonucleotide Therapeutics in Japan for Rare Diseases. 2(1). 22 indexed citations
3.
Nii, Takenobu, Masaki Matsumoto, Kanit Bhukhai, et al.. (2021). The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro. Molecules. 26(7). 1995–1995. 2 indexed citations
4.
Kulkeaw, Kasem, et al.. (2020). A novel method to purify neutrophils enables functional analysis of zebrafish hematopoiesis. Genes to Cells. 25(12). 770–781. 3 indexed citations
5.
Yamada, Makiko, Shinichi Inoue, Daisuke Sugiyama, et al.. (2020). Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition. 48(4). 288–296. 15 indexed citations
6.
Shiozuka, Masataka, et al.. (2018). Academia–industry Cooperation in the Medical Field: Matching Opportunities in Japan. Clinical Therapeutics. 40(11). 1807–1812. 9 indexed citations
7.
Shigeto, Jun, et al.. (2018). Preclinical Toxicity Studies for Regenerative Medicine in Japan. Clinical Therapeutics. 40(11). 1813–1822. 4 indexed citations
8.
Tan, Keai Sinn, Kasem Kulkeaw, Yoichi Nakanishi, & Daisuke Sugiyama. (2017). Expression of cytokine and extracellular matrix mRNAs in fetal hepatic stellate cells. Genes to Cells. 22(9). 836–844. 17 indexed citations
9.
Kulkeaw, Kasem, Tomoko Inoue, Tohru Ishitani, et al.. (2017). Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis. British Journal of Haematology. 180(3). 420–431. 11 indexed citations
10.
Leong, Kok Hoong, Khalijah Awang, Yuka Tanaka, et al.. (2017). Induction of intrinsic apoptosis in leukaemia stem cells and in vivo zebrafish model by betulonic acid isolated from Walsura pinnata Hassk (Meliaceae). Phytomedicine. 26. 11–21. 19 indexed citations
11.
Yamaguchi, Mitsuhiro, Nobuya Kurikawa, Koji Terayama, et al.. (2017). Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor. Bioorganic & Medicinal Chemistry. 25(17). 4817–4828. 8 indexed citations
12.
Sugiyama, Daisuke, Anagha Joshi, Kasem Kulkeaw, et al.. (2016). A Transcriptional Switch Point During Hematopoietic Stem and Progenitor Cell Ontogeny. Stem Cells and Development. 26(5). 314–327. 4 indexed citations
13.
Kummalue, Tanawan, Tomoko Inoue, Yoshie Miura, et al.. (2015). Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells. Experimental Hematology. 43(5). 414–423.e1. 3 indexed citations
14.
Sugiyama, Daisuke, et al.. (2012). TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. Mechanisms of Development. 130(2-3). 195–206. 31 indexed citations
15.
Kulkeaw, Kasem, Tohru Ishitani, Takaaki Kanemaru, Suthat Fucharoen, & Daisuke Sugiyama. (2010). Cold exposure down-regulates zebrafish hematopoiesis. Biochemical and Biophysical Research Communications. 394(4). 859–864. 18 indexed citations
16.
SUGIMOTO, ISAO, et al.. (2008). . Nippon Laser Igakkaishi. 29(1). 26–29. 1 indexed citations
17.
Shibayama, Takahiro, et al.. (2007). Characterization of CS-023 (RO4908463), a Novel Parenteral Carbapenem Antibiotic, and Meropenem as Substrates of Human Renal Transporters. Drug Metabolism and Pharmacokinetics. 22(1). 41–47. 32 indexed citations
18.
Jaffredo, Thierry, Karine Bollérot, Daisuke Sugiyama, R. Gautier, & C. Drevon. (2005). Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cells. The International Journal of Developmental Biology. 49(2-3). 269–277. 54 indexed citations
19.
Sugiyama, Daisuke, Ken-ichi Arai, & Kohichiro Tsuji. (2005). Definitive Hematopoiesis from Acetyl LDL Incorporating Endothelial Cells in the Mouse Embryo. Stem Cells and Development. 14(6). 687–696. 13 indexed citations
20.
Sugiyama, Daisuke, Hiroyuki Kusuhara, Young Ju Lee, & Yuichi Sugiyama. (2003). Involvement of Multidrug Resistance Associated Protein 1 (Mrp1) in the Efflux Transport of 17β Estradiol-D-17β-Glucuronide (E217βG) Across the Blood-Brain Barrier. Pharmaceutical Research. 20(9). 1394–1400. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026